Gao Cai, He Jinzhao, Wang Yiming, Shao Guangying, Lin Simei, Liu Jihan, Ren Chaoqun, Quan Yazhu, Ying Yi, Li Min, Yang Baoxue, Zhou Hong
State Key Laboratory of Natural and Biomimetic Drugs, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
State Key Laboratory of Natural and Biomimetic Drugs, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Department of the Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Transl Res. 2025 Jul 2. doi: 10.1016/j.trsl.2025.06.002.
AKI and CKD are major global health problem, which closely connected and promote each other. The mechanism may be related to maladaptive repair after renal tubular injury. FAK is a non-receptor tyrosine kinase located at the intersection of multiple cell signal transduction pathways. Previous studies have suggested that FAK may be involved in the repair process after kidney injury, but its role and mechanism in the process of AKI to CKD need to be further elucidated. In this study, we found that FAK was up-regulated in AKI to CKD and mainly localized in renal collecting ducts. Therefore, we generated renal collecting duct specific FAK knockout mice, which were treated with RIRI and UUO models to simulate the progression of AKI and CKD. This study for the first time found that the specific knockout of FAK in renal collecting duct can reduce oxidative stress and inflammatory response in the early stage of kidney injury, improve renal function, inhibit renal fibrosis, and significantly prolong the survival time of mice. In terms of mechanism, FAK knockout in renal collecting duct may affect inflammatory cell infiltration through KLF5 signaling pathway, regulate the trend of adaptive repair and maladaptive repair of renal tubular cells after injury, and promote the damaged kidney tubules restore health. Therefore, this study confirmed that loss of FAK function in the renal collecting duct can delay the progression of AKI to CKD by inhibiting inflammation-regulated maladaptive kidney repair, which providing a novel potential strategy for the clinical treatment of AKI to CKD.
急性肾损伤(AKI)和慢性肾脏病(CKD)是全球主要的健康问题,二者紧密相连且相互促进。其机制可能与肾小管损伤后的适应性修复不良有关。黏着斑激酶(FAK)是一种非受体酪氨酸激酶,位于多条细胞信号转导通路的交汇处。既往研究提示,FAK可能参与肾脏损伤后的修复过程,但其在AKI向CKD进展过程中的作用及机制尚需进一步阐明。在本研究中,我们发现FAK在AKI向CKD转变过程中表达上调,且主要定位于肾集合管。因此,我们构建了肾集合管特异性FAK敲除小鼠,并用肾缺血再灌注损伤(RIRI)和单侧输尿管梗阻(UUO)模型处理,以模拟AKI和CKD的进展。本研究首次发现,肾集合管中FAK的特异性敲除可减轻肾损伤早期的氧化应激和炎症反应,改善肾功能,抑制肾纤维化,并显著延长小鼠存活时间。在机制方面,肾集合管中FAK的敲除可能通过KLF5信号通路影响炎性细胞浸润,调节肾小管细胞损伤后适应性修复和适应性修复不良的趋势,促进受损肾小管恢复健康。因此,本研究证实肾集合管中FAK功能缺失可通过抑制炎症调节的适应性肾脏修复不良来延缓AKI向CKD的进展,为AKI向CKD的临床治疗提供了一种新的潜在策略。